The Color of COVID: COVID-19 Vaccines

With racial and ethnic disparities amid COVID-19, how can the approval and distribution of vaccines be handled to ensure that inequities are not further exacerbated?

The COVID-19 pandemic has laid bare inequities in American society. Not only are there racial and ethnic disparities in COVID-19 infections and deaths, but also the pandemic has exacerbated the economic inequities suffered by the poor and middle class. As the federal and state government, Moderna, Pfizer/BioNtech, and AzstraZeneca/Oxford rush to approve and distribute COVID-19 vaccines, they must ensure that it doesn’t cause further inequities.

Facilitated by Keon Gilbert, Dr.Ph., co-founder of Institute for Healing Justice and Equity

Panelists: Ana Santos Rutschman, S.J.D, Saint Louis University School of Law; Harald Schmidt, MA, Ph.D., University of Pennsylvania Perelmen School of Medicine; Ruqaiijah Yearby, J.D., M.P.H., Saint Louis University School of Law